诺思兰德：第六届董事会第二十五次会议决议公告

Core Viewpoint - Norland announced the postponement of its drug research and development project without changing the total investment amount, implementation entity, or the use of raised funds [2] Group 1 - Norland's sixth board of directors held its 25th meeting on December 26, 2025 [2] - The decision to postpone the drug research project does not require submission for shareholder approval [2]